Telogen Effluvium in COVID-19 Patients: A Cross-Sectional Survey

    Faisal Ahmad, Fatima Sajid, Anwar Ul Haq, S. Rizwan, Ayesha Siraj, Muneeza Rizwan
    Image
    Studysummary This study found that 28.8% of post-COVID-19 patients experienced telogen effluvium, and the condition was significantly more frequent in females compared to males.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →